Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $35.89M | $26.2M | +36.99% |
Operating Income | $-253.05M | $-244.29M | -3.58% |
Net Income | $-146.97M | $-123.68M | -18.83% |
EPS (Basic) | $-2.64 | $-2.58 | -2.33% |
EPS (Diluted) | $-2.64 | $-2.58 | -2.33% |
R&D Expense | $226.05M | $212.39M | +6.43% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $1.19B | $1.32B | -9.95% |
Current Assets | $757.21M | $939.62M | -19.41% |
Total Liabilities | $220.47M | — | — |
Current Liabilities | $105.09M | $99.85M | +5.25% |
Stockholders' Equity | $971.06M | $1.1B | -12.11% |
Cash & Equivalents | $130.85M | $171.81M | -23.84% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-178.85M | $-199.65M | +10.42% |
Investing Cash Flow | $-18.29M | $-156.79M | +88.34% |
Financing Cash Flow | $101.24M | $4.74M | +2037.18% |
D&A | $5.11M | $4.22M | +21.11% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -705.0% | -932.4% | +227.39% |
Net Margin | -409.5% | — | — |
ROE | -15.1% | — | — |
ROA | -12.3% | — | — |
Current Ratio | $7.205 | — | — |
Debt to Equity | $0.227 | — | — |
Other companies in Biotechnology